HTGM | HTG Molecular Diagnostics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.4800 - 0.4800
52 Week Range	0.4620 - 24.96
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	725,429
Average Volume	253,915
Shares Outstanding	2,214,230
Market Cap	1,062,830
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2015-05-06

Valuation
Profitability
Growth
Health
P/E Ratio	-0.03
Forward P/E Ratio	N/A
EPS	-17.10
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	53
Country	USA
Website	HTGM

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

HTGM's peers: GENE, ISPC, ME, NDRA, PRPO, TTOO, BIAF

*Chart delayed

Analyzing fundamentals for HTGM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see HTGM Fundamentals page.

Watching at HTGM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HTGM Technicals page.